MODERATE TO SEVERE OPIOID USE DISORDER
Clinical trials for MODERATE TO SEVERE OPIOID USE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE OPIOID USE DISORDER trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE OPIOID USE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for opioid addiction treatment
Disease control CompletedThis study tested a new injectable medication called INDV-6001 in 123 adults with moderate to severe opioid use disorder. The goal was to see how the drug moves through the body, if it is safe, and how well people tolerate it. Participants received multiple doses, and researchers…
Matched conditions: MODERATE TO SEVERE OPIOID USE DISORDER
Phase: PHASE2 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Monthly shot study tests better doses for opioid addiction
Disease control CompletedThis study tested two different doses (100 mg vs 300 mg) of a monthly buprenorphine injection in 785 adults with moderate to severe opioid use disorder. The goal was to see which dose helped people stay in treatment and reduce opioid use. The study also compared a faster versus s…
Matched conditions: MODERATE TO SEVERE OPIOID USE DISORDER
Phase: PHASE4 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC